Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia, and an executive is attending a conference in Chicago.
4 reports, 3 independent
Updated May 27
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia, and an executive is attending a conference in Chicago.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Telix Pharmaceuticals Limited is involved in activities related to Europe.Sub-event
Telix Pharmaceuticals is headquartered in Melbourne, Australia, with an executive attending a conference in Chicago.1 source
Telix is seeking global trial expansion and reporting commercial performance from Indianapolis.1 source
Keep exploring
The entities involved
-
TELIX PHARMACEUTICALS LIMITED
Australian public company
-
Chicago
city and county seat of Cook County, and largest city in State of Illinois, United States of America
-
Melbourne
capital city of Victoria, Australia
Related events
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireTelix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOB
- PR NewswireTelix H1 2025 Results: Investor Webcast Notification MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises
- GlobeNewswireTelix Reports $204M Revenue, Up 63% YOY MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an updat